February 13, 2023
Shionogi reported two additional cases of serious adverse reactions for its oral COVID-19 treatment Xocova (ensitrelvir), bringing the total of such cases to five since the drug’s distribution started in November, according to its latest update. An estimated 28,050 people...read more